{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:53:11Z","timestamp":1791312791261,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIAID Middle Atlantic Regional Center of Excellence (MARCE) grant","award":["U54 AI057168"],"award-info":[{"award-number":["U54 AI057168"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.vaccine.2012.11.007","type":"journal-article","created":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T17:06:00Z","timestamp":1352739960000},"page":"319-326","source":"Crossref","is-referenced-by-count":18,"title":["Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide\/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge"],"prefix":"10.1016","volume":"31","author":[{"given":"Yuhong","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta B.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Buchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Volkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Russell Middaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart N.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.11.007_bib0005","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum salts in vaccines \u2013 US perspective","volume":"20","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.007_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2005.08.002","article-title":"(How) do aluminium adjuvants work?","volume":"102","author":"Brewer","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2012.11.007_bib0015","first-page":"1","article-title":"Immunological adjuvants. Report of a WHO scientific group","volume":"595","author":"WHO","year":"1976","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.007_bib0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nm.2306","article-title":"Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity","volume":"17","author":"Flach","year":"2011","journal-title":"Nat Med"},{"issue":"36","key":"10.1016\/j.vaccine.2012.11.007_bib0025","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1016\/j.vaccine.2007.06.049","article-title":"Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response","volume":"25","author":"Hansen","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.007_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/14760584.6.5.685","article-title":"Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation","volume":"6","author":"Hem","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.007_bib0035","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.vaccine.2008.11.078","article-title":"Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response","volume":"27","author":"Hansen","year":"2009","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2012.11.007_bib0040","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/jps.22555","article-title":"Effect of the strength of adsorption of HIV 1 SF162dV2gp140 to aluminum-containing adjuvants on the immune response","volume":"100","author":"Hansen","year":"2011","journal-title":"J Pharm Sci"},{"issue":"20\u201322","key":"10.1016\/j.vaccine.2012.11.007_bib0045","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/S0264-410X(00)00559-4","article-title":"Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits","volume":"19","author":"Chang","year":"2001","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2012.11.007_bib0050","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0264-410X(02)00556-X","article-title":"Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production","volume":"21","author":"Iyer","year":"2003","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2012.11.007_bib0055","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2004.10.014","article-title":"Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants","volume":"23","author":"Berthold","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.007_bib0060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.vaccine.2006.09.039","article-title":"Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants","volume":"25","author":"Romero Mendez","year":"2007","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2012.11.007_bib0065","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.vaccine.2010.02.085","article-title":"Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response","volume":"28","author":"Noe","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.007_bib0070","first-page":"156","article-title":"Solubilization of aluminum-containing adjuvants by constituents of interstitial fluid","volume":"45","author":"Seeber","year":"1991","journal-title":"J Parenter Sci Technol"},{"issue":"22","key":"10.1016\/j.vaccine.2012.11.007_bib0075","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0264-410X(99)00126-7","article-title":"The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins","volume":"17","author":"Heimlich","year":"1999","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.007_bib0080","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.vaccine.2005.09.048","article-title":"Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid","volume":"24","author":"Jiang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.007_bib0085","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Xiao","year":"2007","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2012.11.007_bib0090","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.007_bib0095","doi-asserted-by":"crossref","first-page":"e20597","DOI":"10.1371\/journal.pone.0020597","article-title":"Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors","volume":"6","author":"Cohen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2012.11.007_bib0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.007_bib0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.vaccine.2012.11.007_bib0110","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.11.007_bib0115","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.007_bib0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"15","key":"10.1016\/j.vaccine.2012.11.007_bib0125","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","article-title":"Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges","volume":"25","author":"Fogg","year":"2007","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2012.11.007_bib0130","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.vaccine.2008.04.017","article-title":"Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies","volume":"26","author":"Golden","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.007_bib0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2007.09.029","article-title":"Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens","volume":"371","author":"Sakhatskyy","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.11.007_bib0140","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.vaccine.2009.09.133","article-title":"Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates","volume":"28","author":"Hooper","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.007_bib0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2005.07.006","article-title":"Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene","volume":"341","author":"Aldaz-Carroll","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.11.007_bib0150","series-title":"Formulation and process development strategies for manufacturing biopharmaceuticals","first-page":"173","article-title":"An empirical phase diagram\/high throughput screening approach to the characterization and formulation of biopharmaceuticals","author":"Joshi","year":"2010"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.007_bib0155","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1002\/jps.22618","article-title":"Multidimensional methods for the formulation of biopharmaceuticals and vaccines","volume":"100","author":"Maddux","year":"2011","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.007_bib0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2005.09.056","article-title":"Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host","volume":"345","author":"Fang","year":"2006","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.007_bib0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(86)90268-1","article-title":"Antibody avidity determination by ELISA using thiocyanate elution","volume":"86","author":"Pullen","year":"1986","journal-title":"J Immunol Methods"},{"issue":"12","key":"10.1016\/j.vaccine.2012.11.007_bib0170","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0501103102","article-title":"The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies","volume":"102","author":"Su","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"31","key":"10.1016\/j.vaccine.2012.11.007_bib0175","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1016\/j.vaccine.2010.05.007","article-title":"Preformulation studies \u2013 The next advance in aluminum adjuvant-containing vaccines","volume":"28","author":"Hem","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2012.11.007_bib0180","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1586\/erv.10.73","article-title":"Vaccines as physically and chemically well-defined pharmaceutical dosage forms","volume":"9","author":"Volkin","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.007_bib0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4161\/hv.2.2.2645","article-title":"Association between immunogenicity and adsorption of a recombinant Streptococcus pneumoniae vaccine antigen by an aluminum adjuvant","volume":"2","author":"Levesque","year":"2006","journal-title":"Hum Vaccin"},{"issue":"14","key":"10.1016\/j.vaccine.2012.11.007_bib0190","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1074\/jbc.M500687200","article-title":"Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens","volume":"280","author":"Jones","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.007_bib0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jps.20762","article-title":"Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants","volume":"96","author":"Peek","year":"2007","journal-title":"J Pharm Sci"},{"issue":"23","key":"10.1016\/j.vaccine.2012.11.007_bib0200","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.01593-09","article-title":"Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5","volume":"83","author":"Benhnia","year":"2009","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.007_bib0205","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.007_bib0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.icb.7100118","article-title":"Correlates of protective immunity in poxvirus infection: where does antibody stand?","volume":"86","author":"Panchanathan","year":"2008","journal-title":"Immunol Cell Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T07:50:38Z","timestamp":1540108238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12016003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0264410X12016003"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}